August 06, 2010
Volume 2, Issue 8
In This Issue
SEC, FDA under orders from White House to allow and promote blatantly illegal acts?
It was just 18 months ago that Geron, the world-leading hoax embryonic stem cell company, which makes its money by hoodwinking investors and robbing spinal cord patients of hope, announced for the 11th time that it was holding a clinical trial which was never going to happen.
For a complete listing on Geron’s tries to pump up stock prices over the past six years through fantasy clinical trials:
How do they get away with it? Because the government is owned by the corporations who want you to forget about Repair Stem Cells since they will destroy the profits of those who have you in a medical prison today. Pretending that embryonics can actually help a real patient ---even one---does just that, when every crooked newspaper and TV network in the land hypes the hoax as if it’s real. Do you think if Don Margolis knows it is not real, the New York Times does not?
While a country-full of controlled (or bribed) newspaper, magazine, and TV medical reporters followed orders and praised the first embryonic trial to the heavens, Don Margolis, Chairman of the Repair Stem Cell Institute, was the only stem cell expert IN THE WORLD to announce in the face of millions of dollars of fake hoopla that IT WOULD NEVER HAPPEN! He alone was right when Geron came up with three different excuses over the next year as to why it didn’t happen, all three of them lies, as you will see below.
Now they come up with Hoax #12---only meant to push up the stock price while disappointing hundreds of thousands of spinal cord paralyzed patients. Of course, the stock price went up 40% friday and monday. So while Obama will probably praise this scam, while every liberal writer is again cheering the defeat of Dubya Bush, and all the media in North America are already screaming their support of the hoax, you, dear readers, will be the only ones in the world to know the truth---once again---from the only man in the world to come out and say it. “IT WON’T HAPPEN, NO MATTER HOW MANY PAID-OFF OR JUST DUMB REPORTERS AND WEBSITES RAVE ABOUT IT. “
JAN. 29, 2009
Geron again cries wolf – and the stock shoots up
company; Geron saw its shares soar after announcing January 22, 2009 that the
FDA had approved testing of its GRNOPC1 in acute spinal cord injury patients.
According to CEO Thomas Okarma, “If safe and effective, the therapy would
provide a viable treatment option for thousands of patients who suffer severe
spinal cord injuries each year.” Don Margolis, who founded The Repair Stem
Cell institute to benefit patients, responded: “Many will benefit from this
P.R. event, but the patients and the taxpayers will lose mightily!”
“Reporters” who have flooded the U.S. with stories about this ‘first’
embryonic stem cell clinical trial would serve the public (and the truth)
better by doing some background research on this boy-who-cried-wolf
company. A half-hour’s research would enlighten them that the true purpose
of the announcement was to pump up the stock’s price over 35% and at the same
time capitalize on our new president’s recent promise to lift our former
president’s restriction on embryonic stem cell research, thus providing
government funds courtesy of every citizen’s taxes.
Mr. Margolis believes the embryonic lobby will never allow any clinical
trial to be held because they know that immune rejection by the patient is
possible and that, based on animal research, brain tumors may be in the
Margolis added, “That is why we at the Repair Stem Cell Institute expect the
embryonic lobby to pull its weight and stop this potential catastrophe in
the making. For a listed company to cynically manipulate stock prices and
raise the hopes of sufferers as Geron does regularly, might be considered a
NOTICE, DEAR READER, THAT THE FIRST TWO PARAGRAPHS ABOVE DESCRIBE EXACTLY WHAT IS HAPPENING AGAIN TODAY!!
FEB 27, 2009
The Company who Cried and Cried and Cried and Cried “Wolf!"
America appears to be a nation in pathological denial. Here’s one extract. Notice all the hype and nonsense.
SURE—EARLY SUMMER---OF WHAT YEAR IN WHAT DECADE?
Spend two minutes watching Don’s video on the subject at: http://www.repairstemcells.org/Education/Stem-Cells-101.aspx which is the home of STEM CELLS 101. Look for Lesson #4.
MARCH 5, 2009
GERON MARCHES ON
AS PAUL HARVEY MIGHT SAY---FOR THE REST OF THE STORY:
stock shot up 35% to $8.50. Then those nice honest dealers on Wall
Street we’ve learned so much about the past six months found $43million
dollars worth of sucker money to buy Geron stock at HOORAY—A 14%
DISCOUNT off the last closing price.
suckers bought about 7.5 million shares of a stock which had just closed at
$7.77. Their bargain price was $6.60 and, for all intents and
purposes the scam was over. Those that bought at $7 to $8.50 woke up
to find their $7.77 stock was only worth $6.60.
trading days later, even the discount buyers were down one dollar a share at
$5.60; and it took another six trading days to get them down to $4.60.
At the end of last week, Geron stock was below where it was before the
FDA approval was announced. Even the discount buyers were down 30%!
And THAT, Dear Reader, is how things work when a science based on lies and hype hooks up with Wall Street. At least those that read our Newsletter couldn’t have been roped on that one.
THE NEXT TWELVE MONTHS 2009-2010
Late in the summer of 2009, Geron announced that the clinical trial would not start on time using some hi-tech nonsense which may or may not have been true but was not the real reason.
The lie was obvious because at www.clinicaltrials.org there never had been an entry for Geron’s hoax trial. Strange, since every clinical trial in the world (now 90,000+ listed) appears long before it starts in order to recruit patients. Geron never even complied with the NIH rules since “Why waste the time” was obvious.
2-3 months later they came out with a different lie as to why the clinical trial was not held. And a few months after that, the third obvious lie was tried by Okarma and company.
Now the 2010 scam starts.
Here is a response by Dr. David Prentice, the ONLY doctor in the USA to protest, since no MD would dare risk his career by telling the truth. The American Medical Mafia whacks out those who rat out the hoax:
So stay tuned and watch your intentionally-misinforming newspapers praise this scam again and again—for they are the real reason for the embryonic science-fiction---Geron is but a tool which is allowed to get away with hoax after hoax because they are doing their corporation-controlled government’s bidding. “Corporation Control” is how Mussolini and Hitler were legally elected and Americans don’t yet understand that is exactly how its current president was elected.
The media’s job is to convince the public that stem cells which can actually help people are snake oil, so that they won’t protest when corrupt governments owned by big business refuse to let profits be affected by the greatest medicine ever laid at the feet of humankind—Repair Stem Cells.
(We’re still looking for the first Embryonic Stem Cell victory of the decade.)
Doctors regenerated tissue from the patients' nose and bone marrow stem cells to create tracheas biologically identical to the patients' original organs. Both patients underwent the transplant in early July and were released from the hospital just weeks after the surgery, according to the Associated Press.
One of the patients was able to speak again only a few days after the surgery, said Dr. Paolo Macchiarini, professor of surgery at the University of Barcelona in Spain and the head surgeon in the cases.
"They are back to the home, able to speak, able to socialize with everybody," Giovannini told the Associated Press. "Having this quality of life is wonderful."
According to Dr. Mark Iannettoni, head of the department of cardiothoracic surgery at University of Iowa, a trachea is a fragile organ because it is mostly cartilage, which has a poor blood supply.
"Once damaged, it is difficult to get it to heal correctly," said Iannettoni.
Growing a Working Trachea
Trachea cancer is resistant to chemotherapy and radiation and attempts to replace the trachea with mechanical devices have not been effective. However, Dr. Eric Lambright, surgical director of lung transplant at Vanderbilt University Medical Center, said that using a patient's own stem cells not only could help to rebuild the fragile tissue, but also potentially could bypass the risk of having the organ rejected.
"These patients [are] otherwise sentenced to a significantly horrible quality of life related to their tumors and ... heroic measures may indeed be very appropriate," said Lambright.
According to Macchiarini, the team collected stem cells from the patients' nose and bone marrow, and grew two different types of tissues from the cells that resembled the different surfaces of the trachea. The tissues covered the outer and inner linings of the donor trachea.
Although these were the first stem cell transplants Macchiarini performed on trachea cancer patients, this is not the first trachea transplant of its kind. In 2008, Macchiarini and his surgical team successfully performed a trachea transplant using adult stem cells on a woman who suffered from tuberculosis.
The team transplanted a new windpipe with tissue grown from her own stem cells and did not need to administer anti-rejection drugs, according to the case report, published in the December 2008 Lancet.
ED NOTE: You can bet Dr. Macchiarini will never rise in the ranks of embryonic-controlled ISSCR.
SUPER STEMMYS – DORIS AND THE SUPERCELLS
Super Stemmys, Doris and the Supercells is the first ever children’s story on stem cells.
A stem cell named Doris and her stem cell friends must all join forces and work together to repair an ailing heart and defeat Morbidus the Vile.
100% of the proceeds from sales of
Super Stemmys, Doris and the Supercells
Go to the Repair Stem Cell Institute (RSCI) to help patients.
Newsletter is for educational purposes only and not to be taken as medical